FINWIRES · TerminalLIVE
FINWIRES

$KRYS

2 stories mentioning KRYS

Every FINWIRES story that references KRYS, newest first.

Insider Trading

Krystal Biotech Insider Sold Shares Worth $7,702,984, According to a Recent SEC Filing

Krish S Krishnan, 10% Owner, Director, President and Chief Executive Officer, on June 04, 2026, sold 25,000 shares in Krystal Biotech (KRYS) for $7,702,984. Following the Form 4 filing with the SEC, Krishnan has control over a total of 1,590,253 common shares of the company, with 1,450,253 shares held directly and 140,000 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1711279/000129870926000009/xslF345X05/wk-form4_1780699113.xml

$KRYS
Wire

Krystal Biotech's Medicine to Treat Wounds in Dystrophic Epidermolysis Bullosa Gets Approval in UK

Krystal Biotech's (KRYS) beremagene geperpavec to treat wounds in patients with dystrophic epidermolysis bullosa has received approval from the UK's Medicines and Healthcare products Regulatory Agency for use from birth onward, the agency said in a Friday statement.The medication, which is available in the form of gel, demonstrated 67% complete healing rate in a study of 31 patients at six months, according to the statement.Dystrophic epidermolysis bullosa is a rare genetic condition characterized by fragile skin and recurrent wounds.Price: $308.93, Change: $-7.37, Percent Change: -2.33%

$KRYS